Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging treatments for allergic rhinitis.

Morgan Andersson1

  • 1Department of Otorhinolaryngology, University Hospital, SE-221 85 Lund, Sweden. Morgan.Andersson@onh.lu.se

Expert Opinion on Emerging Drugs
|November 13, 2003
PubMed
Summary

Allergic rhinitis affects many young people, driving research for better treatments. New remedies must be clinically effective, cost-effective, and improve upon current options like antihistamines and intranasal steroids.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HealthSWEDE: costs with sublingual immunotherapy-a Swedish questionnaire study.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2021
Same author

Aging-in-Place: Residents' Attitudes and Floor Plan Potential in Apartment Buildings From 1990 to 2015.

HERD·2021
Same author

The impact of the physical environment for caregiving in ordinary housing: Experiences of staff in home- and health-care services.

Applied ergonomics·2021
Same author

Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy.

The Journal of allergy and clinical immunology·2020
Same author

Is it possible to feel at home in a patient room in an intensive care unit? Reflections on environmental aspects in technology-dense environments.

Nursing inquiry·2019
Same author

The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial.

The Journal of allergy and clinical immunology·2019

Area of Science:

  • Immunology
  • Pharmacology
  • Clinical Medicine

Background:

  • Allergic rhinitis prevalence is increasing, particularly in younger populations in Westernized countries.
  • Understanding the pathophysiology of allergic reactions fuels research into novel therapeutic strategies.
  • Existing treatments like antihistamines and intranasal steroids have limitations and room for improvement.

Purpose of the Study:

  • To explore current research trends in developing new remedies for allergic rhinitis.
  • To evaluate the potential benefits of targeting specific mediators or cytokines in allergic inflammation.
  • To assess the criteria for novel allergic rhinitis treatments, including clinical efficacy and cost-effectiveness.

Main Methods:

  • Review of current pharmacological research focusing on selective agents.
  • Analysis of the allergic inflammatory process and potential intervention points.
  • Comparison of novel treatment concepts with existing therapies.

Main Results:

  • Pharmacological research targets selective agents to inhibit mediators or cytokines.
  • The complexity of allergic inflammation raises questions about the efficacy of late-stage intervention.
  • Improvements in clinical potency and reduced side effects are desired for current treatments.

Conclusions:

  • Novel treatments for allergic rhinitis must demonstrate superior clinical and cost-effectiveness compared to existing options.
  • Intervention early in the allergic process may be crucial for drug efficacy.
  • Continued research is needed to develop improved and cost-effective therapies for allergic rhinitis.

Related Experiment Videos